Skip to main content

Table 3 Final PCA loadings with procrustes transformation by country

From: A cross-cultural investigation into the dimensional structure and stability of the Barriers to Research and Utilization Scale (BARRIERS Scale)

Item

Australia

United Kingdom

Taiwan

Procrustes congruence

1

2

3

4

1

2

3

4

1

2

3

4

AUS

UK

TAI

ADOPT1

0.79

0.15

0.07

0.01

0.80

0.32

0.14

0.18

0.83

0.21

0.21

0.22

0.97

0.85

0.84

ADOPT2

0.86

0.19

0.06

0.08

0.80

0.26

0.11

0.20

0.80

0.21

0.24

0.23

0.96

0.88

0.82

ADOPT3

0.75

0.25

0.12

−0.03

0.78

0.25

0.25

0.06

0.81

0.26

0.25

0.16

0.93

0.89

0.81

ADOPT5

0.72

0.20

0.14

0.05

0.71

0.43

0.17

0.07

0.74

0.25

0.32

0.26

0.93

0.81

0.75a

ORGAN1

0.11

0.73

0.08

0.01

0.32

0.64

−0.16

0.29

0.54

0.53

0.26

0.21

0.99

0.87

0.78a

ORGAN2

0.13

0.68

0.16

−0.09

0.32

0.69

0.04

0.18

0.46

0.60

0.34

0.23

0.95

0.91

0.81

ORGAN3

0.07

0.57

0.11

0.16

0.06

0.67

0.24

−0.03

0.14

0.80

0.13

0.23

0.95

0.90

0.96

ORGAN4

0.26

0.61

−0.06

0.14

0.25

0.71

0.14

0.12

0.54

0.55

0.28

0.23

0.91

0.92

0.78a

ORGAN5

0.21

0.73

0.13

0.01

0.10

0.73

0.19

−0.01

0.31

0.76

0.26

0.18

0.96

0.94

0.93

ORGAN6

0.13

0.76

0.12

−0.03

0.35

0.63

0.25

−0.01

0.46

0.66

0.24

0.21

0.98

0.81

0.87

INNOV1

0.15

−0.01

0.70

0.03

0.22

0.14

0.54

0.34

0.22

0.17

0.78

0.26

0.97

0.80

0.91

INNOV2

0.15

0.09

0.77

0.08

0.29

0.21

0.58

0.43

0.42

0.17

0.75

0.28

0.97

0.74a

0.83

INNOV3

0.10

0.09

0.77

0.08

−0.07

0.27

0.80

0.15

0.25

0.21

0.79

0.26

0.98

0.95

0.89

INNOV4

−0.20

0.25

0.70

−0.03

−0.04

0.28

0.78

0.14

0.21

0.26

0.76

0.31

0.91

0.95

0.87

INNOV5

0.15

0.16

0.67

0.24

0.28

0.23

0.71

−0.04

0.40

0.29

0.57

0.37

0.89

0.90

0.70a

COMM2

−0.05

0.00

−0.02

0.71

0.08

0.09

0.14

0.83

0.33

0.16

0.30

0.69

1.00

0.96

0.80

COMM3

0.11

0.11

0.41

0.67

0.17

0.07

0.36

0.67

0.30

0.27

0.36

0.69

0.85

0.86

0.76a

COMM4

0.16

0.01

0.16

0.69

0.38

−0.16

0.08

0.56

0.13

0.25

0.21

0.76

0.96

0.89

0.89

COMM5

−0.06

0.05

0.00

0.71

0.28

−0.03

0.26

0.46

0.18

0.15

0.29

0.77

0.99

0.82

0.88

  1. Major loadings are in italics
  2. ADOPT characteristics of the adopter: the clinician’s research values, skills, and awareness, ORGAN characteristics of the organisation: setting barriers and limitations, INNOV characteristics of the innovation: qualities of the research, COMM characteristics of the communication: presentation and accessibility of the research
  3. aLower than ideal congruence coefficient